Literature DB >> 11243398

Extramedullary infiltrates at diagnosis have no prognostic significance in children with acute myeloid leukaemia.

M M Bisschop1, T Révész, M Bierings, J F van Weerden, E R van Wering, K Hählen, A van der Does-van den Berg.   

Abstract

This retrospective study was designed to review the relative frequency and prognostic significance of extramedullary infiltrates in children with acute myeloid leukaemia (AML). The registration data and initial discharge summaries were reviewed for all children diagnosed with AML, and registered by the Dutch Childhood Leukaemia Study Group (DCLSG). Between 1972 and 1998, 477 children were diagnosed with AML. Of these patients, 120 (25.1%) had extramedullary leukaemia (EML) at diagnosis. Four categories of EML were found: skin, soft tissue or bone, gingival infiltration and central nervous system (CNS) involvement. Patients who presented with gingival infiltrates, were older than those without EML or those in the other EML subgroups, had a high initial WBC count and a high proportion of M4/M5 morphological variants. This type of presentation could indicate a special biological entity. Univariate analysis of prognostic factors in patients treated after 1985 with intensive protocols showed that initial WBC count and the presence of favourable cytogenetic findings were significant. The presence of EML at diagnosis had no significant effect on event-free survival. In a stepwise multiple regression analysis only favourable cytogenetic findings remained significant.

Entities:  

Mesh:

Year:  2001        PMID: 11243398     DOI: 10.1038/sj.leu.2401971

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  18 in total

1.  Acute myeloid leukemia with mediastinal myeloid sarcoma refractory to acute myeloid leukemia therapy but responsive to L-asparaginase.

Authors:  Hiroyoshi Takahashi; Katsuyoshi Koh; Motohiro Kato; Hiroshi Kishimoto; Eiji Oguma; Ryoji Hanada
Journal:  Int J Hematol       Date:  2012-05-29       Impact factor: 2.490

Review 2.  Unravelling chloroma: review of imaging findings.

Authors:  Anuradha Singh; Pawan Kumar; Sheragaru Hanumanthappa Chandrashekhara; Atin Kumar
Journal:  Br J Radiol       Date:  2017-05-23       Impact factor: 3.039

3.  Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia.

Authors:  Uri Rozovski; Maro Ohanian; Farhad Ravandi; Guillermo Garcia-Manero; Stefan Faderl; Sherry Pierce; Jorge Cortes; Zeev Estrov
Journal:  Leuk Lymphoma       Date:  2014-11-03

4.  The presence of central nervous system disease at diagnosis in pediatric acute myeloid leukemia does not affect survival: a Children's Oncology Group study.

Authors:  Donna L Johnston; Todd A Alonzo; Robert B Gerbing; Beverly J Lange; William G Woods
Journal:  Pediatr Blood Cancer       Date:  2010-09       Impact factor: 3.167

5.  Clinical characteristics of pediatric patients with myeloid sarcoma without bone marrow involvement in Japan.

Authors:  Takashi Taga; Toshihiko Imamura; Kentaro Nakashima; Naoko Maeda; Akihiro Watanabe; Yuji Miyajima; Sachi Sakaguchi; Hitoshi Sano; Daiichiro Hasegawa; Hirohide Kawasaki; Souichi Adachi; Masatoshi Takagi; Katsuyoshi Koh; Atsushi Manabe; Tomohiko Taki; Yasushi Ishida
Journal:  Int J Hematol       Date:  2018-07-03       Impact factor: 2.490

6.  Minimally differentiated acute myeloid leukemia (FAB AML-M0) is associated with an adverse outcome in children: a report from the Children's Oncology Group, studies CCG-2891 and CCG-2961.

Authors:  Draga Barbaric; Todd A Alonzo; Robert B Gerbing; Soheil Meshinchi; Nyla A Heerema; Dorothy R Barnard; Beverly J Lange; William G Woods; Robert J Arceci; Franklin O Smith
Journal:  Blood       Date:  2006-12-07       Impact factor: 22.113

7.  Neoplastic meningitis in patients with acute myeloid leukemia scheduled for allogeneic hematopoietic stem cell transplantation.

Authors:  Martin Bommer; Stephanie von Harsdorf; Hartmut Döhner; Donald Bunjes; Mark Ringhoffer
Journal:  Haematologica       Date:  2010-07-27       Impact factor: 9.941

Review 8.  Central Nervous System Involvement in Adults with Acute Leukemia: Diagnosis, Prevention, and Management.

Authors:  Shilpa Paul; Nicholas J Short
Journal:  Curr Oncol Rep       Date:  2022-02-10       Impact factor: 5.075

9.  Extramedullary Disease in Adult Acute Myeloid Leukemia Is Common but Lacks Independent Significance: Analysis of Patients in ECOG-ACRIN Cancer Research Group Trials, 1980-2008.

Authors:  Chezi Ganzel; Judith Manola; Dan Douer; Jacob M Rowe; Hugo F Fernandez; Elisabeth M Paietta; Mark R Litzow; Ju-Whei Lee; Selina M Luger; Hillard M Lazarus; Larry D Cripe; Peter H Wiernik; Martin S Tallman
Journal:  J Clin Oncol       Date:  2016-10-10       Impact factor: 44.544

10.  Leukemias and lymphomas: treatment and prophylaxis of the central nervous system.

Authors:  Janet L Franklin; Jonathan Finlay
Journal:  Curr Treat Options Neurol       Date:  2006-07       Impact factor: 3.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.